ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, will offer EMS World Expo attendees the opportunity to experience the company’s expanded portfolio of advanced CPR and acute critical care technologies, along with its integrated data solutions, in booth 1215 on October 5 7 at the Ernest N. Morial Convention Center in New Orleans.
Featured as part of the expanding ZOLL family of products is the ResQCPR™ System, which was approved by the U.S. Food and Drug Administration (FDA) as the first and only CPR adjunct device indicated to improve the likelihood of survival in adults who have experienced non-traumatic sudden cardiac arrest. Also new is the Web-based Mobile Care Connect™, an online system that enables facilities to schedule and manage transports from mobile devices. This simplifies the entire scheduling process and eliminates much of the chaos sometimes involved with scheduling patient transports.
The one-of-a-kind rescuer experience available from ZOLL at EMS World Expo includes:
The ZOLL CPR Challenge Experience
Using the ZOLL X Series® Monitor/Defibrillator, show attendees will have a chance to test their CPR skills with and without the benefit of Real CPR Help®, ZOLL’s real-time CPR feedback technology. ZOLL’s RescueNet® Case Review software will provide participants with a detailed analysis of their CPR performance. Twice a day, top scorers will receive a Fitbit. ZOLL’s breakthrough CPR technologies, in conjunction with scenario-based training, have been shown to almost triple survival-to-hospital discharge with favorable neurological outcomes.1
The Patient Transport Experience
Attendees will have the opportunity to experience moving patients with ongoing mechanical CPR using the AutoPulse® Resuscitation System. Participants will maneuver a patient through a course of stairs and tight turns while the AutoPulse performs continuous high-quality CPR. Designed for Resuscitation on the Move™, a recent study showed that the AutoPulse had a significant survival benefit when compared to manual CPR when resuscitation efforts lasted longer than 16 minutes.2 And in a meta-analysis of 12 comparative clinical trials, the AutoPulse improved the odds of return of spontaneous circulation (ROSC) by 62% when compared to manual CPR.3
The True-to-Life Experience with the ResQCPR System
For those interested in trying the new ResQCPR System, comprised of the ResQPUMP® and the ResQPOD® 16, a true-to-life simulation experience is available. The two-device combination was shown in a large clinical trial to improve survival to one year from out-of-hospital, non-traumatic cardiac arrest by 49% when compared to treatment with conventional cardiopulmonary resuscitation (CPR).4
The RescueNet Experience
The ZOLL RescueNet Experience shows attendees the journey of patient data from dispatch through discharge. When EMS software solutions are truly integrated, critical incident and patient data follow the patient from dispatch all the way through to post-event billing, saving EMS agencies both time and money.
The Ventilator Experience
With ZOLL’s EMV+® and AEV® Ventilators, participants will have a unique anatomical experience by seeing firsthand how real pig lungs adapt to each ventilator mode. Both full-featured ventilator models are lightweight, rugged, and have a long 10-hour battery life to accommodate the needs of EMS.
About ZOLL Medical Corporation
ZOLL Medical Corporation (zoll.com), an Asahi Kasei Group Company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care.
About Asahi Kasei
The Asahi Kasei Group (asahi-kasei.co.jp) is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the material, homes, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.
1. Bobrow BJ, et al. The influence of scenario-based training and real-time audiovisual feedback on pre-hospital cardiopulmonary resuscitation quality and survival from out-of-hospital cardiac arrest. Ann Emerg Med. 2013 Jul;62(1):47 56.e1. Epub 2013 Mar 7.
2. Olsen JA, et al. Chest compression duration influences outcome between integrated load-distributing band and manual CPR during cardiac arrest. Acta Anaesthesiologica Scandinavica. 2015;60:222 229.
3. Westfall M, et al. Mechanical vs. manual chest compressions in out-of-hospital cardiac arrest: a meta-analysis. Crit Care Med. 2013 Jul;41(7):1782 1789.
4. ResQCPR System Summary of Safety and Effectiveness Data approved by Food and Drug Administration 2015.
Copyright © 2016 ZOLL Medical Corporation. All rights reserved. AEV, AutoPulse, EMV+, Mobile Care Connect, Real CPR Help, RescueNet, ResQCPR, ResQPOD, ResQPUMP, Resuscitation on the Move, X Series, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All other trademarks are the property of their respective owners.